Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
16.21
-0.62 (-3.68%)
At close: Jul 21, 2026, 4:00 PM EDT
16.26
+0.05 (0.31%)
After-hours: Jul 21, 2026, 7:58 PM EDT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $1.71 billion as of July 21, 2026. Its market cap has increased by 21.26% in one year.
Market Cap
1.71B
Enterprise Value
2.11B
1-Year Change
21.26%
Ranking
Category
Stock Price
$16.21
ChartMarket Cap Chart
Since July 22, 2021, Sarepta Therapeutics's market cap has decreased from $5.52B to $1.71B, a decrease of -69.00%. That is a compound annual growth rate of -20.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 1.74B | -22.91% |
| Dec 31, 2025 | 2.26B | -80.91% |
| Dec 31, 2024 | 11.84B | 31.14% |
| Dec 29, 2023 | 9.03B | -20.69% |
| Dec 30, 2022 | 11.38B | 44.86% |
| Dec 31, 2021 | 7.86B | 42.33% |
| Jul 22, 2021 | 5.52B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.81B |
| Nanobiotix | 1.81B |
| Stoke Therapeutics | 1.78B |
| Immunocore Holdings | 1.75B |
| Zymeworks | 1.72B |
| Ascentage Pharma Group International | 1.72B |
| MapLight Therapeutics | 1.69B |
| Fortrea Holdings | 1.68B |